Funder: Breakthrough T1D
Due Dates (Anticipated): October 2026
Funding Amounts: Up to $200,000 for one year (includes max 10% indirect costs); not renewable.
Summary: Seed funding for bold, high-risk research with the potential for major breakthroughs in type 1 diabetes.
Key Information: Preliminary data not required; project must be plausibly testable and focused on type 1 diabetes.